The research antibodies and reagents market has evolved owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global research antibodies and reagents market is expected to witness significant growth in the coming years.
The Research antibodies and reagents market is projected to reach USD 14.1 billion by 2025
from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.
Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793
The research antibodies and
reagents market players are focusing on various organic and inorganic growth
strategies, such as product launches, acquisition, collaboration, partnerships,
agreements, and expansion to increase their market foothold. The prominent
market players are Thermo Fisher Scientific (US), Merck Group (Germany), Abcam
plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell
Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher
Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza
(Switzerland), GenScript (China), and BioLegend (US). The market is highly
competitive, with a large number of leading market players based across
developed regions such as the US and Europe. However, smaller players have
emerged from niche markets to compete with global players on the basis of price
and product innovation. Due to intense competition, major market players are
increasingly focusing on expanding their geographic presence into the
high-growth emerging markets and strengthening their market competitiveness by
acquiring smaller players with the desired product quality or geographic
presence.
Thermo Fisher Scientific
Inc. develops and manufactures high-end analytical instruments, laboratory
equipment, software, consumables, reagents, and services for scientific
research, analysis, discovery, and diagnostics. The company serves customers
through premier brands—Thermo Scientific, Applied Biosystems, Invitrogen,
Fisher Scientific, and Unity Lab Services. The company operates through four
basic segments, namely, Life Sciences Solutions, Analytical Instruments,
Specialty Diagnostics, and Laboratory Products & Services. It provides
reagents, instruments, and consumables used in biological and medical research,
discovery, the production of new drugs and vaccines, and the diagnosis of
diseases through its Life Sciences Solutions segment. The Life Sciences
Solutions segment includes four primary businesses, of which the biosciences
business provides various reagents and antibodies for conducting biological and
medical research.The company operates in more than 180 countries across North
America, Europe, Asia, the Middle East, Africa, and Latin America. Some of its
major subsidiaries are ABgene Limited (UK), Athena Diagnostics, Inc. (US),
Thermo Fisher Scientific C.V. (Netherlands), Life Technologies Corporation
(US), Prionics AG (Switzerland), Thermo Detection de Mexico, S.A. de C.V.,
Fisher Scientific Japan, Ltd., and Fisher Scientific (SEA) Pte. Ltd.
(Singapore).
Get Data as per your Format and
Definition | REQUEST FOR CUSTOMIZATION:-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=94212793
The Merck Group is a
multinational pharmaceutical, life science, and chemical company. The company
has three major business divisions—Healthcare, Life Sciences, and Performance
Materials. The Life Sciences division is organized into three business areas: research
solutions, process solutions, and applied solutions. The products and services
offered by the Life Sciences division are used in R&D and manufacturing of
biotechnological and pharmaceutical drug therapies, as well as in research and
application laboratories. The research solutions segment provides consumables
for filtration and sample preparation, reagents and kits for cell biology
experiments, and small tools and consumables for cell analysis. This segment
mainly focusses on academia and pharmaceutical research institutions. The
company provides more than 300,000 products across 66 countries. Its
manufacturing facilities are l ocated in Bedford (US), Jaffrey (US), Darmstadt
(Germany), Molsheim (France), Beijing (China), and Bengaluru (India). Merck has
a strong product and technology portfolio for research antibodies and offers
innovative solutions for the life science industry. The company offers
high-quality research-use products to a wide end-user base under the brand name
MilliporeSigma. With a strong brand and wide geographic coverage in more than
120 countries, Merck has a well-established presence in the research antibodies
market. It also plans to expand its life science offerings by investing in
R&D activities and through planned business synergies. In 2019, it invested
around USD 2.54 billion in R&D activities.
No comments:
Post a Comment